41 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Jeffrey, Surgeon in Stanford, CA?
Dr. Stefanie Jeffrey, MD is a Surgeon, who primarily practices in Stanford, CA with 1 additional practice location. She has been practicing for over 41 years and is board certified. Dr. Jeffrey completed her residency at UCSF School of Medicine. Dr. Jeffrey is fluent in English and Dutch; Flemish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Jeffrey’s office at (650) 498-6004.
What are Areas of Expertise for Dr. Jeffrey?
Dr. Stefanie Jeffrey, MD is a highly-rated, board-certified Surgeon known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Jeffrey empowers patients to confidently navigate their health journey, specializing in Breast Cancer, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Jeffrey is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Jeffrey go to medical school and complete their residency?
Residency: UCSF School of Medicine | University of California, San Francisco
Is Dr. Jeffrey board certified as a Surgeon?
Yes, Dr. Stefanie Jeffrey, MD is board certified by the American Board of Surgery , American Board of Surgery since 1985
What languages does Dr. Jeffrey speak?
Dr. Jeffrey and their clinical team can communicate with patients in the following languages:
Dutch; Flemish
English
What conditions does a Surgeon like Dr. Jeffrey typically treat?
As a Surgeon, conditions treated by Dr. Stefanie Jeffrey may include:
Please contact Dr. Jeffrey's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does a Surgeon like Dr. Jeffrey typically perform?
As a Surgeon, procedures performed by Dr. Stefanie Jeffrey may include:
- Abdominal Wall Reconstruction
- Amputation
- Appendicitis / Appendectomy
- Brain Aneurysm Treatment
- Brain Surgery
- Brain Tumor Evaluation
- Central Line Placement
- Cerebral Shunt
Please contact Dr. Jeffrey's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Jeffrey accept my insurance?
Please contact Dr. Jeffrey's office to confirm accepted insurance plans.
Where is Dr. Jeffrey's office located?
What hospitals are Dr. Jeffrey affiliated with?
Castle Connolly Top Hospital
This doctor is affiliated with a Castle Connolly Top Hospital.
Dr. Jeffrey has admitting privileges at the following hospitals:
Recognitions
Awards
John and Marva Warnock Professor, Stanford University
Certificate of Special Congressional Recognition, Congresswoman Anna
John and Marva Warnock Faculty Scholar in Cancer Research, Stanford U
Elsbach-Richards Faculty Scholar, Stanford University
Inc. - Best Doctors, Inc
Cum Laude in Chemistry and Physics, Harvard University
NASA Space Act Board Award, National Aeronautics and Space Administra
Stanford Fellow, Stanford University
Bessie Legarda Memorial Award, Makati Medical Center, Philippines
Cowell Outstanding Faculty Physician Award, Stanford University
Fellow, American College of Surgeons
AOA Honor Medical Society, UCSF
Selected for inclusion in The Best Doctors in America, Woodward/White
Publications
Single cell mutatiol alysis of PIK3CA in circulating tumor cells
, 2014
Isolation and mutatiol alysis of circulating tumor cells from lung cancer patients with magnetic
, 2013
Circulating tumor cells versus tumor-derived cell-free D
, 2013
Colorectal cancer diagnostics: biomarkers, cell-free D
, 2013
Impact of vigation on Knowledge
Single Cell Profiling of Circulating Tumor Cells
, 2012
Multiplex molecular alysis of CTCs.
, 2012
Adipose levels of polybromited diphenyl ethers and risk of breast cancer
, 2011
Distinctive Responsiveness to Stromal Sigling Accompanies Histologic Grade Programming of Cancer
, 2011
Characterization of molecular subtypes of Korean breast cancer
, 2010
Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
, 2010
A Phenotype-Based Model for Ratiol Selection of Novel Targeted Therapies in Treating Aggressive
, 2009
Isolating highly enriched populations of circulating epithelial cells
, 2009
D copy number alterations and expression of relevant genes in triple-negative breast cancer
, 2008
Basal carcinoma of the breast revisited: an old entity with new interpretations
, 2008
Cancer biomarker profiling with microRs
, 2008
MRI-guided radiofrequency ablation of breast cancer: Prelimiry clinical experience
, 2008
R extraction from ten year old formalin-fixed paraffin-embedded breast cancer samples
, 2007
Disease-specific genomic alysis: identifying the sigture of pathologic biology
, 2007
Transcriptomic sigtures in breast cancer
, 2007
Lysyl oxidase is essential for hypoxia-induced metastasis
, 2006
Cell trapping in activated micropores for functiol alysis.
, 2006
Cell trapping in activated micropores for functiol alysis
, 2006
A streamlined platform for high-content functiol proteomics of primary human specimens
, 2005
MRI features of mucosa-associated lymphoid tissue lymphoma in the breast
, 2005
Genomics-based prognosis and therapeutic prediction in breast cancer.
, 2005
Rates of reexcision for breast cancer after magnetic resonce imaging
, 2005
Gene expression profiles
, 2005
Immortalization-associated gene sigture in breast cancer
, 2005
Magnetic resonce imaging of suspicious breast masses seen on one mammographic view.
, 2004
A molecular 'sigture' of primary breast cancer cultures; patterns resembling tumor tissue
, 2004
Distribution of persistent, lipid-soluble chemicals in breast and abdomil adipose tissues
, 2004
Central carbon metabolism genes that predict disease
, 2004
Predictors of reexcision findings and recurrence after breast conservation
, 2003
The diagnosis and magement of pre-invasive breast disease
, 2003
Microarray alysis reveals a major direct role of D copy number alteration
, 2002
MR imaging features of infiltrating lobular carcinoma of the breast: Histopathologic correlation
, 2002
Optimization and evaluation of T7 based R linear amplification protocols for cD microarray alysis
, 2002
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical
, 2001
Locally advanced breast cancer: is surgery necessary?
, 2001
Molecular portraits of human breast tumours
, 2000
Systematic variation in gene expression patterns in human cancer cell lines
, 2000
Characterization of breast lesion morphology with delayed 3DSSMT: An adjunct to dymic breast MRI
, 2000
Magement of breast cancer after Hodgkin's disease
, 2000
Genome-wide alysis of D copy-number changes using cD microarrays
, 1999
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
, 1999
Breast disease: Dymic spiral MR imaging
, 1998
Three-dimensiol shaded-surface rendering of MR images of the breast: technique, applications
, 1998
Prelimiry experience with power Doppler imaging of solid breast masses
, 1997
AXILLARY LYMPHADENECTOMY FOR BREAST-CANCER WITHOUT AXILLARY DRAIGE
, 1995
ABDOMIL ABSCESS - A SURGICAL STRATEGY
, 1983
RESECTION OF GASTRINOMAS
, 1983
CIMETIDINE IN THE TREATMENT OF ZOLLINGER-ELLISON SYNDROME
, 1983
Case report. Intramural hematoma of the cecum following blunt trauma.
, 1982
RESTING STATE IN NORMAL AND SIMIAN VIRUS-40 TRANSFORMED CHINESE-HAMSTER LUNG-CELLS
, 1976
ROLE FOR HEME IN MAMMALIAN PROTEIN-SYNTHESIS - ACTIVATION OF AN INITIATION-FACTOR
, 1974
GLUCOSE-METABOLISM IN NEISSERIA-GONORRHOEAE
, 1974
Patient-derived xenografts of triple
, 2014
Single cell mutational analysis of PIK3CA in circulating tumor cells
, 2014
Isolation and mutational analysis of circulating tumor cells from lung cancer patients with
, 2013
Circulating tumor cells versus tumor-derived cell-free DNA
, 2013
Colorectal cancer diagnostics: biomarkers, cell-free DNA
, 2013
Nuclear Localization of the Mitochondrial Factor HIGD1A during Metabolic Stress
, 2013
Impact of Navigation on Knowledge
Single Cell Profiling of Circulating Tumor Cells
, 2012
Multiplex molecular analysis of CTCs.
, 2012
Adipose levels of polybrominated diphenyl ethers and risk of breast cancer
, 2011
A pharmacogenomic method for individualized prediction of drug sensitivity
, 2011
Distinctive Responsiveness to Stromal Signaling Accompanies Histologic Grade Programming of Cancer
, 2011
Characterization of molecular subtypes of Korean breast cancer
, 2010
Stem cells in human breast cancer
, 2010
Focal amplification and oncogene dependency of GAB2 in breast cancer
, 2010
Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
, 2010
A Phenotype-Based Model for Rational Selection of Novel Targeted Therapies in Treating Aggressive
, 2009
Isolating highly enriched populations of circulating epithelial cells
, 2009
CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer
, 2008
New models and online calculator for predicting non
, 2008
DNA copy number alterations and expression of relevant genes in triple-negative breast cancer
, 2008
Basal carcinoma of the breast revisited: an old entity with new interpretations
, 2008
Cancer biomarker profiling with microRNAs
, 2008
New models and online calculator for predicting non
, 2008
Estrogen receptor-negative invasive breast cancer
, 2008
MRI-guided radiofrequency ablation of breast cancer: Preliminary clinical experience
, 2008
RNA extraction from ten year old formalin-fixed paraffin-embedded breast cancer samples
, 2007
MagSweeper: an automated system for high efficiency and specificity capture of live circulating
, 2007
Oxidative stress pathways highlighted in tumor cell immortalization
, 2007
Disease-specific genomic analysis: identifying the signature of pathologic biology
, 2007
Transcriptomic signatures in breast cancer
, 2007
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
, 2007
Discovery and validation of breast cancer subtypes
, 2006
Radiation-induced effects on gene expression: An in vivo study on breast cancer
, 2006
MRI-guided needle localization of suspicious breast lesions: results of a freehand technique
, 2006
Predicting non-sentinel lymph node involvement in breast cancer patients.
, 2006
Lysyl oxidase is essential for hypoxia-induced metastasis
, 2006
LOX is essential for hypoxia-induced metastasis
, 2006
Development of a new device for high throughput isolation of live circulating tumor cells.
, 2006
Cell trapping in activated micropores for functional analysis.
, 2006
Cell trapping in activated micropores for functional analysis
, 2006
A streamlined platform for high-content functional proteomics of primary human specimens
, 2005
MRI features of mucosa-associated lymphoid tissue lymphoma in the breast
, 2005
Adipose levels of dioxins and risk of breast cancer
, 2005
Genomics-based prognosis and therapeutic prediction in breast cancer.
, 2005
Rates of reexcision for breast cancer after magnetic resonance imaging
, 2005
Gene expression profiles
, 2005
TP53 mutations among molecular subtypes of HER2-positive tumors
, 2005
Immortalization-associated gene signature in breast cancer
, 2005
The evolution of accelerated
, 2004
Magnetic resonance imaging of suspicious breast masses seen on one mammographic view.
, 2004
A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue
, 2004
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast
, 2004
Distribution of persistent, lipid-soluble chemicals in breast and abdominal adipose tissues
, 2004
Central carbon metabolism genes that predict disease
, 2004
Predictors of reexcision findings and recurrence after breast conservation
, 2003
The diagnosis and management of pre-invasive breast disease
, 2003
Gene expression profiling of breast carcinomas.
, 2002
Microarray analysis reveals a major direct role of DNA copy number alteration
, 2002
MR imaging features of infiltrating lobular carcinoma of the breast: Histopathologic correlation
, 2002
Expression array technology in the diagnosis and treatment of breast cancer.
, 2002
Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray
, 2002
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical
, 2001
Breast cancer: Variables affecting sentinel lymph node visualization at preoperative
, 2001
Freehand iMRI-guided large-gauge core needle biopsy
, 2001
Locally advanced breast cancer: is surgery necessary?
, 2001
Expedition inspiration consensus 2001
, 2001
Isosulfan blue affects pulse oximetry
, 2000
Molecular portraits of human breast tumours
, 2000
Controversies in sentinel lymph node biopsy for breast cancer
, 2000
Systematic variation in gene expression patterns in human cancer cell lines
, 2000
Characterization of breast lesion morphology with delayed 3DSSMT: An adjunct to dynamic breast MRI
, 2000
Management of breast cancer after Hodgkin's disease
, 2000
Radiofrequency ablation of breast cancer - First report of an emerging technology
, 1999
Isosulfan blue affects pulse oximetry
, 1999
Genome-wide analysis of DNA copy-number changes using cDNA microarrays
, 1999
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
, 1999
Breast disease: Dynamic spiral MR imaging
, 1998
Breast lesion localization: A freehand, interactive MR imaging-guided technique
, 1998
Three-dimensional shaded-surface rendering of MR images of the breast: technique, applications
, 1998
Preliminary experience with power Doppler imaging of solid breast masses
, 1997
Ultrasound tissue characterization of breast biopsy specimens: Expanded study
, 1996
Value of sonographic identification of breast masses in excised specimens in the breast imaging
, 1996
AXILLARY LYMPHADENECTOMY FOR BREAST-CANCER WITHOUT AXILLARY DRAINAGE
, 1995
THE IMPORTANCE OF THE LUMPECTOMY SURGICAL MARGIN STATUS IN LONG-TERM RESULTS OF BREAST-CONSERVATION
, 1995
ABDOMINAL ABSCESS - A SURGICAL STRATEGY
, 1983
RESECTION OF GASTRINOMAS
, 1983
CIMETIDINE IN THE TREATMENT OF ZOLLINGER-ELLISON SYNDROME
, 1983
Case report. Intramural hematoma of the cecum following blunt trauma.
, 1982
RESTING STATE IN NORMAL AND SIMIAN VIRUS-40 TRANSFORMED CHINESE-HAMSTER LUNG-CELLS
, 1976
ROLE FOR HEME IN MAMMALIAN PROTEIN-SYNTHESIS - ACTIVATION OF AN INITIATION-FACTOR
, 1974
GLUCOSE-METABOLISM IN NEISSERIA-GONORRHOEAE
, 1974
What is Dr. Jeffrey's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Jeffrey's National Provider Identifier (NPI) number is 1326174285.
What common questions do patients ask about Dr. Jeffrey?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Jeffrey
What is Dr. Stefanie Jeffrey's specialty?
Dr. Jeffrey is a Surgeon near Stanford, CA.
What does a Surgeon do?
General surgeons are experts in diagnosing and managing surgical conditions which includes preoperative, operative, and postoperative care, as well as addressing complications. Their expertise include the areas such as the alimentary tract, breast, abdomen, skin and soft tissue, endocrine system, head and neck, pediatric surgery, surgical critical care, surgical oncology, trauma, burns, and vascular surgery. General surgeons increasingly utilize minimally invasive and endoscopic techniques to provide proper care. In addition to this, many general surgeons have expertise in transplantation, plastic, and cardiothoracic surgery.
Is Dr. Stefanie Jeffrey affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Jeffrey is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Surgeon?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Surgeon. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Dr. Stefanie Jeffrey accepting new patients in Stanford, CA?
Yes, Dr. Stefanie Jeffrey is accepting new patients at this time.
Does Dr. Stefanie Jeffrey offer online booking?
Please contact Dr. Jeffrey's office at (650) 498-6004 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Dr. Stefanie Jeffrey?
Please contact Dr. Jeffrey's office at (650) 498-6004 to schedule an appointment.
Where is Dr. Jeffrey's office located?
Dr. Jeffrey's offices are located in Stanford, CA and Palo Alto, CA.
Which board certifications does Dr. Stefanie Jeffrey have?
Dr. Stefanie Jeffrey is certified by the American Board of Surgery.
Other Surgeon Near Stanford, CA
Ophthalmologist
Accepting patientsSurgeon
Accepting patientsSurgeon
Accepting patients